Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OMB OKAYS FDA CONSOLIDATED CAMPUS: ADVERTISING FOR POSSIBLE SITES

This article was originally published in The Gray Sheet

Executive Summary

OMB OKAYS FDA CONSOLIDATED CAMPUS: ADVERTISING FOR POSSIBLE SITES for the agency's centers for devices, drugs and biologics, and the commissioner's office in Montgomery County, Maryland will be kicked off by the General Services Administration March 21 in The Washington Post. GSA initiated the advertising as the next step towards FDA consolidation following the Office of Management and Budget's March 15 approval of an $888 mil., two-campus plan.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel